Thierry Verne

Thierry Verne serves as CEO at Olyos Group. Olyos Group operates in the pharmaceuticals sector with approximately 530.0 employees. The company is headquartered in Mougins, Provence-Alpes-Cote d'Azur.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • We have verified contacts for 2 executives at Olyos Group.
• • 299 executive contacts are available in Provence-Alpes-Cote d'Azur.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Apache Varnish Mobile Friendly Google Font API WordPress.org

pharmaceutical manufacturing natural health nutritional supplements pharmaceutical group holistic health family wellness medications organic nutrition food supplements medical expertise clinical research product development health solutions essential trace elements dermatological products pain relief gynecology rheumatology stress management fertility weight loss sports nutrition quality assurance safe manufacturing health innovation global market expansion fda approved products r&d collaboration e-commerce development clinical trials nutrition experts trust in healthcare patient loyalty family health dietary formulations nutraceuticals sustainable practices social responsibility international presence pharmacy partnerships bio-certified products raw material selection consumer health wellbeing personalized nutrition health education environmental ethics clinical recommendations pharmacy sales pharmaceuticals medical health care health wellness & fitness hospital & health care

JB

Jonathan Bienfait Directeur Général Adjoint - Deputy CEO at Olyos Group

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

Outreach Guidance — pharmaceuticals Sector

Executives like Thierry Verne in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Olyos Group.

Thierry Verne's Position in the MessageCEO Database

• •Thierry Verne is 1 of 2 verified executive contacts we track at Olyos Group.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •298 verified executive contacts in Provence-Alpes-Cote d'Azur are in the database.
• •12 verified contacts work at pharmaceuticals companies in the 530.0 employee range (same size as Olyos Group).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Thierry Verne directly?

Thierry Verne's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Olyos Group. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Thierry Verne work for?

Thierry Verne is CEO at Olyos Group, a company in the pharmaceuticals sector with 530.0 employees. The company is based in Mougins, Provence-Alpes-Cote d'Azur.

Can I pitch or sell to Thierry Verne?

As CEO at Olyos Group, Thierry Verne is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Thierry Verne directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Thierry Verne in?

Thierry Verne works in the pharmaceuticals industry as CEO at Olyos Group. MessageCEO provides verified contact information for executives across all major industries.

Is Thierry Verne's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Thierry Verne's profile is kept up-to-date with the latest available information.

Last updated: July 22, 2026